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ABSTRACT
Background: Individuals with Lewy body dementia (LBD) typically exhibit impairments in attentional
and executive function. Current pharmacological treatments have limited efficacy, with associated side
effects. Transcranial direct current stimulation (tDCS) may represent an alternative treatment, as cognitive
improvements have been demonstrated in healthy individuals. However, no studies to date have assessed
the feasibility of tDCS in an LBD population. The aim of this preliminary study, therefore, was to assess the
tolerability of tDCS, as well as its effects upon attentional and visuoperceptual performance, in LBD patients.
Methods: Thirteen participants completed attentional (simple reaction time, choice reaction time, and digit
vigilance) and forced-choice visuoperceptual (angle and motion perception) tasks before and after one 20-min
session of active tDCS (0.08 mA/cm2). The anodal electrode was applied to the left dorsolateral prefrontal
cortex and the cathodal electrode was applied to the right deltoid. Attentional (task accuracy and reaction
time to correct answers) and visuoperceptual (task accuracy and difficulty) outcome measures were compared
using paired t-tests.
Results: All participants tolerated stimulation and did not report any side effects during or immediately after
stimulation. Post-stimulation improvements were observed in the choice reaction time (increased percentage
of correct answers; p = 0.01) and digit vigilance (reduced mean reaction time to correct answers; p = 0.02)
attention tasks. Visuoperceptual task performance did not improve (all p-values > 0.05).
Conclusions: Attentional, but not visuoperceptual, improvements were observed following stimulation in LBD
patients. Larger-scale, placebo-controlled trials are needed to confirm whether tDCS is a useful treatment
option for attentional deficits in LBD.
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Introduction
Lewy body dementias (LBDs) include dementia
with Lewy bodies (DLB) and Parkinson’s disease
with dementia (PDD). Individuals with DLB and
PDD share a common underlying alpha-synuclein
neuropathology and display similar neuropsycho-
logical impairments, including attentional and
visuoperceptual deficits (McKeith et al., 2005;
Emre et al., 2007; Lippa et al., 2007).
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Neuroscience, Campus for Ageing and Vitality, Newcastle University,
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The treatment of attentional and cognitive
impairments in LBD is typically limited to the
use of cholinesterase inhibitors (McKeith et al.,
2000; Emre et al., 2004); however, due to
the limited efficacy of these agents and their
associated side effects, alternative treatments are
urgently needed. One potentially promising non-
pharmacological intervention is transcranial direct
current stimulation (tDCS), a simple, non-invasive,
and inexpensive technique inwhich aweak electrical
current is delivered to the brain through two
electrodes soaked in saline or conductive gel.
This approach has a modulatory effect upon
cortical excitability, where these effects are polarity-
dependent: anodal stimulation typically increases
2 G. J. Elder et al.
and cathodal stimulation typically decreases the
underlying neural membrane potential (Stagg and
Nitsche, 2011).
The application of tDCS to the dorsolateral
prefrontal cortex (DLPFC) has been shown to
enhance cognitive functions including working
memory, visuomotor co-ordination and decision-
making in healthy individuals (Antal et al., 2004;
Fregni et al., 2005; Fecteau et al., 2007; Zaehle
et al., 2011). Importantly, beneficial cognitive
effects following DLPFC stimulation have also
been demonstrated in relevant clinical populations,
including patients with Alzheimer’s disease and
Parkinson’s disease (Elder and Taylor, 2014).
Additionally, these positive effects may persist
beyond the immediate period of stimulation. For
example, Doruk and colleagues (2014) recently
demonstrated that in patients with Parkinson’s
disease, ten consecutive sessions of anodal
tDCS delivered to the left or right DLPFC
led to short-term and longer-term (measured
one month post-stimulation) improvements in
executive functioning, compared with placebo
stimulation.
As attentional and executive function deficits
are observed within the LBDs, this is suggestive
of frontal dysfunction (Johns et al., 2009). This
is supported by neuropsychological studies which
have observed impairments in frontally dependent
attentional and executive tasks in LBD (Ballard
et al., 2001; Calderon et al., 2001; Aarsland et al.,
2003); pathologically, Lewy bodies are commonly
found in the anterior frontal and temporal regions
(Yoshimura, 1983; Kuzuhara and Yoshimura,
1993), and in addition, neuroimaging studies have
shown that frontal atrophy is a feature of LBD
(Burton et al., 2002, 2004). Thus, there is a
broad context to suggest that there may be a
reduced top-down influence of the frontal cortex
in LBD. Previous studies have observed beneficial
effects of DLPFC stimulation upon attention
and executive functioning (Fecteau et al., 2007;
Gladwin et al., 2012), and the left DLPFC has
been implicated in top-down cognitive control
(MacDonald et al., 2000). Given this empirical and
theoretical basis, we therefore hypothesized that
the application of anodal tDCS to the DLPFC
might benefit attentional and executive function
in individuals with LBD. However, to date, the
feasibility and tolerability, or the potential benefits
of tDCS upon attentional and executive function,
have not been examined in an LBD patient
group.
Therefore, the primary aim of this preliminary
study was to assess the feasibility of using tDCS in
individuals with LBD, and to investigate the effects
of tDCS upon attentional function in LBD.
Methods
Participants
Sixteen participants who met diagnostic criteria for
either probable DLB or PDD (McKeith et al.,
2005; Emre et al., 2007), as assessed by two
experienced clinicians (J.P.T. and H.K.), were
recruited from the movement disorders service
at the Institute of Neurosciences, Kolkata, India.
The diagnosis was verified by detailed physical,
neurological, and neuropsychiatric examinations,
including hematology and biochemistry screening,
thyroid function, syphilis serology, vitamin B12
and folate level tests, and chest X-rays. Structural
imaging (magnetic resonance imaging or computed
tomography scans) were performed on six of the 16
participants, when clinically suggested, in order to
exclude other neurodegenerative etiologies.
Participants were included if they were 60
years of age; had a Mini-Mental State Examination
(MMSE; Folstein et al., 1975) score of 16;
and were stable on anti-Parkinsonian medication
or cholinesterase inhibitors for a period of one
month prior to participation. Exclusion criteria
included skin allergies; a history of excess
alcohol intake; concurrent major psychiatric illness;
significant/severe physical illness or comorbidities;
other neurological disorders; current/previous visual
impairment due to glaucoma, cataract, or macular
degeneration; metallic or electronic implants; and
significant motor fluctuations. All participants
provided written informed consent and the study
was approved by the local ethics committee.
Measures
Participants completed several clinical measures of
cognitive and motor function prior to stimulation
in order to provide information regarding disease
severity. These included the MMSE (Folstein et al.,
1975), theMontreal Cognitive Assessment (MoCA;
Nasreddine et al., 2005) and Part III of the Unified
Parkinson’s Disease Rating Scale (UPDRS-III;
Goetz et al., 2008).
Medication use
Information regarding the use of cholinesterase
inhibitors, anti-depressant and anti-Parkinsonian
medication was also obtained. The anti-
Parkinsonian medication equivalent levodopa
dose was calculated, using levodopa conversion
formulae reported elsewhere (Tomlinson et al.,
2010), and is expressed in milligrams (mg).
Procedure
Participants completed one brief practice session of
the attentional and visuoperceptual tasks, consisting
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Figure 1. Attentional and visuoperceptual tasks. Task A (simple reaction time): a target (X) was displayed (maximum 3,000 ms with a
varying inter-stimulus interval) and participants were required to respond as quickly as possible. Task B (choice reaction time): Participants
were required to respond to an arrow, which pointed left or right (displayed for a maximum of 3,000 ms) as quickly as possible and
indicating the direction in which the arrow pointed. Task C (digit vigilance): Participants were required to respond to the target digit (9;
displayed on the right of the screen) when the digit displayed in the center of the screen (0–9; cycling at a rate of 500 ms) matched the
target. Tasks D (angle) and E (motion perception): Participants were required to indicate whether the item displayed on the bottom left
or the bottom right matched the target item (displayed in the top center of the screen) in terms of the angle (Task D) or the speed of
motion (Task E). For both visuoperceptual tasks (Tasks D and E), the difficulty levels for both tasks were adjusted depending on whether
the previous trial was correct, where a correct answer increased the difficulty by one step and an incorrect answer reduced the difficulty by
three steps.
of five practice trials per task. Participants then
completed one full run of the computer tasks
(lasting for approximately 10 min) immediately
prior to stimulation, and repeated the tasks 10
min post-stimulation. Participants were tested in
their “on” state with regard to their Parkinsonism;
this was verified by ensuring that dopaminergic
medication had been administered in the previous 2
h and by assessment of motor function immediately
prior to stimulation.
Three attentional (simple reaction time (SRT);
choice reaction time (CRT); digit vigilance (DV));
and two forced-choice visuoperceptual (angle and
motion perception) tasks were used; these tasks have
previously been demonstrated to be differentially
affected in LBD patients compared with controls
and other dementia groups (Wesnes et al., 2002;
Mosimann et al., 2004). These visuoperceptual
tasks are not dependent upon prefrontal regions
(Wood et al., 2011) and performance was therefore
hypothesized to be unlikely to be affected by
DLPFC stimulation. Full details of the tasks are
described elsewhere (Mosimann et al., 2004; Wood
et al., 2011; 2013) and in Figure 1. Tasks were
presented on a laptop PC and responses were
recorded using response button boxes, which were
held either in the dominant hand or in both hands,
depending on the task.
Transcranial direct current stimulation
A single session of stimulation (2.8 mA) was
delivered for 20 min using an Eldith DC Stimulator
(Magstim, Whitland, UK), through two 35-cm2
electrodes in 0.9% saline-soaked bags (equivalent
current density: 0.08mA/cm2). This level of current
density has been previously used, with no reported
adverse effects, in other dementia cohort studies
(Huey et al., 2007; Cotelli et al., 2014). The anodal
electrode was placed over the left DLPFC (50%
between F3 and FP1) using the International 10–20
system (Jasper, 1958). The cathodal electrode was
placed on the right deltoid muscle. All participants
received active stimulation. After the stimulation
session, participants were asked to provide feedback
regarding their experience of the stimulation;
similarly, patients and their families were contacted
24 h post-stimulation and were asked whether any
residual side effects were present.
Statistical analysis
Attentional and visuoperceptual task performances
were compared before and after stimulation using
paired t-tests. Attentional (SRT, CRT, and DV)
task outcome measures included the percentage
of correct answers and the mean reaction time
(RT) to correct answers. Visuoperceptual outcome
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Table 1. Participant demographic and assessment data (n = 13)
DLB (n = 5) PDD (n = 8)
............................................................................................................................................................................................................................................................................................................................
Age (years): mean (SD) 65.00 (7.71) 64.63 (8.16)
Gender: (male/female) 3/2 7/1
Duration of motor symptoms (years since onset): mean (SD) 3.80 (2.39) 11.75 (3.73)
Duration of cognitive symptoms (years since onset): mean (SD) 4.00 (2.91) 2.63 (1.51)
Presence of visual hallucinations: n (%) 2 (40) 7 (87.5)
Presence of delusions: n (%) 3 (60) 7 (87.5)
Presence of apathy: n (%) 4 (80) 8 (100)
Presence of excessive daytime sleepiness: n (%) 2 (40) 4 (50)
Presence of depression or anxiety: n (%) 3 (60) 6 (75)
Presence of cognitive fluctuations: n (%) 3 (60) 6 (75)
MMSE: mean (SD) 20.60 (3.05) 22.00 (2.56)
MoCA: mean (SD) 17.60 (3.65) 19.38 (2.45)
UPDRS-III: mean (SD)a 12.75 (5.56) 28.50 (9.44)
On cholinesterase inhibitors: n (%) 1 (20) 0 (0)
On anti-Parkinsonian medication, n (%) 5 (100) 8 (100)
On anti-depressant medication, n (%) 0 (0) 3 (37.5)
Levodopa equivalent dose (mg): mean (SD) 320.00 (168.08) 935.50 (599.38)
Notes: DLB: Dementia with Lewy bodies; PDD: Parkinson’s disease with dementia; MMSE: Mini-Mental State Examination; MoCA:
Montreal Cognitive Assessment; UPDRS-III: Unified Parkinson’s Disease Rating Scale Motor Subscale.
aUPDRS-III data missing for one participant.
measures included the percentage of correct
answers and the task difficulty, expressed either as
degree values (angle task, where a lower degree
value indicates better performance) or relative
speed values (cars task, where a lower relative
speed indicates a better performance). Outliers
(2 SD) were removed from each RT task. As
the aim of the current preliminary study was to
assess the feasibility and tolerability of tDCS in
LBD participants, analyses were not adjusted for
multiple comparisons. Effect sizes are reported as
Cohen’s dz.
Results
Three participants were excluded from the study
prior to stimulation, due to a poor understanding
of task instructions. This resulted in a final sample
of 13 participants (8 PDD; 5 DLB; Mean, Mage
= 64.77 years, SDage = 7.66 years). Demographic
details are included in Table 1. All participants
tolerated stimulation and did not report any
side effects, other than a brief tingling sensation
underneath the electrodes, during or immediately
after stimulation. No adverse events were reported.
The percentage of CRT correct answers signi-
ficantly increased following stimulation (t(12) =
−2.98, p = 0.01, dz = 0.83). DV improvements
were also shown, where the mean RT to correct
answers (t(11) = 2.77, p = 0.02, dz = 0.80) was
significantly reduced following stimulation. Eleven
participants (84.6%) showed a positive CRT task
response, displaying an increased percentage of
correct answers following stimulation, and nine
participants (69.2%) showed a positive DV task
response, with a reduced mean RT to correct
answers following stimulation. No other significant
post-stimulation differences were shown in the
remaining attentional or visuoperceptual tasks (all
p-values > 0.05). The results are summarized in
Table 2.
Discussion
This preliminary study indicates that the use
of tDCS, with a current density of 0.08
mA/cm2, is both feasible and well-tolerated in a
group of individuals with LBD, as no residual
post-stimulation side effects were reported by
participants or their families. This study also
demonstrated that a single 20-min session of tDCS,
applied to the left DLPFC, led to post-stimulation
improvements to some aspects of attentional, but
not visuoperceptual, function in LBD patients.
In particular, there were improvements in CRT
accuracy and in DV reaction times, although there
was also a broader tendency for post-stimulation
improvements in all other CRT and DV attentional
measures. This differential benefit is likely to be
due to the placement of electrode over the DLPFC
rather than parietal or visual areas, since previous
studies have shown that stimulation delivered
to the DLPFC enhances working memory and
decision-making (Fregni et al., 2005; Fecteau et al.,
2007), and in the case of left DLPFC stimulation,
can enhance attentional function (Gladwin et al.,
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Table 2. Attention and visuoperceptual task performance pre- and post-tDCS stimulation (n = 13)
PRE-STIMULATION POST-STIMULATION
ATTENTION TASKS MEAN SD MEAN SD EFFECT SIZE (dz)
...................................................................................................................................................................................................................................................................................................................
SRT: correct answers (%) 94.87 7.77 94.36 8.86 0.13
SRT: mean RT (ms; correct answers)a 454.65 130.63 453.65 139.41 0.01
CRT: correct answers (%) 71.79∗ 28.34 87.69∗ 20.92 0.83
CRT: mean RT (ms; correct answers)a 620.44 202.90 608.78 157.18 0.12
DV: correct answers (%) 75.64 15.60 81.41 26.53 0.30
DV: mean RT (ms; correct answers)a 632.85∗ 100.16 582.93∗ 58.42 0.80
Visuoperceptual tasks
Angle: correct answers (%) 85.11 7.36 84.88 7.15 0.02
Angle: difficulty (degrees)b 24.01 16.56 23.63 18.99 0.02
Motion: correct answers (%) 70.36 13.18 75.90 11.49 0.44
Motion: difficulty (relative speed)c 2.61 0.97 2.56 1.00 0.07
Notes: SRT: simple reaction time; CRT: choice reaction time; DVT: digit vigilance; ms: milliseconds; RT: reaction time.
an = 12.
bLower degree value indicates better performance.
cLower relative speed indicates better performance.
∗p < 0.05.
2012). Speculatively, our data suggest that as
the left DLPFC has a suggested role in top-
down cognitive control (MacDonald et al., 2000),
anodal stimulation, which can modulate cortical
excitability by increasing the membrane potential
(Stagg and Nitsche, 2011), might help improve the
degree of top-down influence of the left DLPFC in
LBD.
Whilst not placebo-controlled, the results of
the present study may also support the notion
that visuoperceptual performance in LBD is less
dependent on fronto-executive function; posterior
cortical function may be more relevant for
these tasks and this would be consistent with
the parieto-occipital deficits apparent in LBD
(Colloby et al., 2002). It is likely that task-specific
electrode montages will be needed to improve
visuoperceptual function in LBD; the application of
anodal stimulation to right parietal areas has been
shown to result in visuoperceptual improvements
within healthy individuals (Bolognini et al., 2010).
Therefore, the efficacy of anodal stimulation to
parietal areas should be tested within LBD.
Limitations of the current study include the
absence of a sham condition and the lack of
correction for multiple comparisons in our analyses.
However, by its nature, this study is exploratory in
terms of highlighting potential benefits, determining
tolerability, and helping to inform stimulation
parameters; the details of which are currently
lacking in LBD and can be determined by studies
with small sample sizes and studies that are
open-label in design (Elder and Taylor, 2014).
Although the present study assessed a small sample
of patients, a current density of 0.08 mA/cm2,
delivered for a period of 20 min, was shown to
be both acceptable and tolerable in LBD patients.
Whilst this level of current density has previously
been used in other dementia cohort studies (Huey
et al., 2007; Cotelli et al., 2014), this has not
been the case in LBD, and importantly, these
stimulation parameters could be used in future
placebo-controlled studies in LBD.
While post-stimulation performance improve-
ments were not observed across all task measures,
the influence of training effects cannot be excluded
from the present study. For this reason, placebo-
controlled trials are necessary to confirm these
results. However, the present study contributes
important pilot data in LBD, as it has been
recommended that the results of all studies,
including those which are negative, are reported in
order to advance the clinical utility of tDCS and
to allow the inclusion of eligible studies in future
meta-analyses (Elder and Taylor, 2014).
Finally, it was not possible to examine whether
stimulation differentially benefits DLB or PDD
patients in the present study; certainly whilst
there is significant overlap neuropathologically and
clinically between both conditions (McKeith et al.,
2005; Emre et al., 2007; Lippa et al., 2007),
differences between the two groups have been
suggested (Park et al., 2011). Nevertheless, these
preliminary data suggest that tDCS may benefit
both patient populations, thus supporting large-
scale trials in both patient groups.
In conclusion, this study indicates that tDCS is
feasible and is well tolerated in an LBD population,
adding to the current lack of data in this patient
group. This study also provides tentative evidence
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to suggest that the delivery of tDCS to the
left DLPFC might benefit attentional function
in LBD. However, larger placebo-controlled trials
with repeated stimulation sessions are needed, and
are now justified, in an LBD population to confirm
this; promising data in PD have suggested that
tDCS can offer sustained benefits upon executive
functioning (Doruk et al., 2014) and it would be
relevant to explore if these effects are carried over
into LBD.
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